A Single Agent Phase II Study of Depsipeptide (FK228)in the Treatment of Cutaneous T-cell Lymphoma
|Effective start/end date||2/9/06 → 6/30/08|
- CHARLES RIVER LAB, INC
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.